205 related articles for article (PubMed ID: 3200858)
21. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
[TBL] [Abstract][Full Text] [Related]
22. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air.
Luceri F; Pieraccini G; Moneti G; Dolara P
Toxicol Ind Health; 1993; 9(3):405-13. PubMed ID: 8367883
[TBL] [Abstract][Full Text] [Related]
23. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
[TBL] [Abstract][Full Text] [Related]
24. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
[TBL] [Abstract][Full Text] [Related]
25. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
26. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.
Dallinga JW; Pachen DM; Wijnhoven SW; Breedijk A; van 't Veer L; Wigbout G; van Zandwijk N; Maas LM; van Agen E; Kleinjans JC; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):571-7. PubMed ID: 9681524
[TBL] [Abstract][Full Text] [Related]
27. The use of biomarkers in epidemiology: the example of bladder cancer.
Vineis P
Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
[TBL] [Abstract][Full Text] [Related]
28. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer.
Martone T; Airoldi L; Magagnotti C; Coda R; Randone D; Malaveille C; Avanzi G; Merletti F; Hautefeuille A; Vineis P
Int J Cancer; 1998 Feb; 75(4):512-6. PubMed ID: 9466649
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous solid-phase extraction and gas chromatographic-mass spectrometric determination of hemoglobin adducts from tobacco-specific nitrosamines and aromatic amines.
Kutzer C; Branner B; Zwickenpflug W; Richter E
J Chromatogr Sci; 1997 Jan; 35(1):1-6. PubMed ID: 8989869
[TBL] [Abstract][Full Text] [Related]
30. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
31. Comparison of exposure to selected cigarette smoke constituents in adult smokers and nonsmokers in a European, multicenter, observational study.
Lindner D; Smith S; Leroy CM; Tricker AR
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1524-36. PubMed ID: 21613391
[TBL] [Abstract][Full Text] [Related]
32. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons.
Riffelmann M; Müller G; Schmieding W; Popp W; Norpoth K
Int Arch Occup Environ Health; 1995; 68(1):36-43. PubMed ID: 8847111
[TBL] [Abstract][Full Text] [Related]
33. Haemoglobin adducts formed by aromatic amines in smokers: sources of inter-individual variability.
Ronco G; Vineis P; Bryant MS; Skipper PL; Tannenbaum SR
Br J Cancer; 1990 Apr; 61(4):534-7. PubMed ID: 2331440
[TBL] [Abstract][Full Text] [Related]
34. Carotenoids/vitamin C and smoking-related bladder cancer.
Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
[TBL] [Abstract][Full Text] [Related]
35. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke.
Vineis P; Talaska G; Malaveille C; Bartsch H; Martone T; Sithisarankul P; Strickland P
Int J Cancer; 1996 Jan; 65(3):314-6. PubMed ID: 8575850
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometric analysis of tobacco-specific hemoglobin adducts.
Schäffler G; Betz C; Richter E
Environ Health Perspect; 1993 Mar; 99():187-9. PubMed ID: 8319620
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological models of carcinogenesis: the example of bladder cancer.
Vineis P
Cancer Epidemiol Biomarkers Prev; 1992; 1(2):149-53. PubMed ID: 1306098
[TBL] [Abstract][Full Text] [Related]
38. Gender- and smoking-related bladder cancer risk.
Castelao JE; Yuan JM; Skipper PL; Tannenbaum SR; Gago-Dominguez M; Crowder JS; Ross RK; Yu MC
J Natl Cancer Inst; 2001 Apr; 93(7):538-45. PubMed ID: 11287448
[TBL] [Abstract][Full Text] [Related]
39. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
[TBL] [Abstract][Full Text] [Related]
40. Haemoglobin adducts from aromatic amines and tobacco specific nitrosamines in pregnant smoking and non smoking women.
Birgit Branner Cornelia Kutzer Wolfgang Wickenpflug Gerhard Scherer Wolf-Dieter Heller Elmar Richter
Biomarkers; 1998; 3(1):35-47. PubMed ID: 23899255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
